Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Epilepsy × Medical Marijuana × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neurodevelopmental Disorders 1 Neoplasms 1 Marijuana Abuse 1 Epilepsy 1

Interventions

ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surgical Procedures, Operative 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Registries 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neuropsychological Tests 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Mass Screening 1 Magnetoencephalography 1 Lurasidone Hydrochloride 1 Labetalol 1 Histocompatibility Testing 1 Haloperidol 1 Fosfomycin 1 Clozapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05863910 2023-11-30

CAN-RWE

University of Manitoba

Marijuana Abuse, Epilepsy, Neoplasms, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡